07.18 scoring disease activity - university of manchester · physical function health assessment...
TRANSCRIPT
![Page 1: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/1.jpg)
Scoring disease activity in myositis
Dr Hector Chinoy PhD FRCP@drhectorchinoy
Senior Lecturer / Honorary Consultant RheumatologistSalford Royal NHS Foundation Trust
Manchester Academic Health Science CentreThe University of Manchester, UK
![Page 2: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/2.jpg)
Idiopathic inflammatory myopathy (IIM):A heterogeneous group of rare autoimmune muscle disorders
Rare disease, annual incidence 5-10/million
2 peaks of onset: (5-15 years)
(30-50 years)
Patterns of disease
(rule of 1/3’s):
Monogenic
Relapsing/remitting
Chronic persistent
Lack of evidence base for treatment
Steroid & immunoresponsive
Treatment phases: induction/maintenance of
remission
Different IIM subtypes with commonality of myositis
Extra-muscular features
eg skin, lung, cardiac, malignancy
![Page 3: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/3.jpg)
Myositis Spectrum Disease Antibodies & Clinical Associations in Adult Myositis
Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.
J Intern Med. 2016 Jul;280(1):8-23
![Page 4: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/4.jpg)
Always worthChecking ANA
pattern for clues
Gunawardena H. The Clinical Features of Myositis-Associated Autoantibodies: a Review. Clin Rev Allergy Immunol. 2017 Feb;52(1):45-57.
![Page 5: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/5.jpg)
Treatment of IIM is challenging:diagnosis, assessing disease, treatment success?
Correct diagnosis
• other myopathies may have similar clinical presentation (also PM vs IBM)• inflammation on biopsy does not exclude other diagnoses• treatment resistance should prompt reappraisal of diagnosis
Assessing disease
• muscle weakness… is it activity (ongoing immune-mediated process), or damage (fatty replacement/ atrophy)?• poor prognostic features may direct drug selection/ treatment strategy (lung, cardiac, dysphagia, malignancy)
Treatment success measured as improvement in major manifestations of disease…by muscle strength & improvement in skin rash or organ involvement
![Page 6: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/6.jpg)
DD, 66 year old male
• Referral from Rheumatology, Preston• 5 year history, gradual onset of proximal weakness, no dysphagia• Struggling to get out of car, low chairs, stairs• ESR normal, CK 829, improved on steroids to 101• EMG – complex repetitive discharges• ANA 1/2560 speckled, Ro/La positive, no sicca symptoms• Commenced on azathioprine & steroids – no worse & no better
![Page 7: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/7.jpg)
Examination
• Deltoid and quadriceps wasting• Neck flexor weakness 9/10• Shoulder abduction, elbow flexion 8/10• Hip flexion/extension 8/10• Finger flexor weakness• No fasciculations
![Page 8: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/8.jpg)
Review of muscle biopsy
• Initial report– CD8+ inflammatory cells– Regenerating muscle fibres– No inclusion bodies / vacuoles
• Further review and staining at Salford Royal– Positive staining for p62 and HLA-1
– COX negative fibres
![Page 9: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/9.jpg)
What is the diagnosis?
A: PolymyositisB: Myofibrillary myopathyC: Sporadic inclusion body myositisD: Adult onset dystrophinopathyE: Miyoshi myopathy
![Page 10: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/10.jpg)
What is the diagnosis?
A: PolymyositisB: Myofibrillary myopathyC: Sporadic inclusion body myositisD: Adult onset dystrophinopathyE: Miyoshi myopathy
![Page 11: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/11.jpg)
Assumptions made
• Proximal weakness• +ANA/Ro• Positive muscle biopsy/EMG• Biochemical response to steroids• Patient subjectively felt better
![Page 12: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/12.jpg)
Revised Diagnosis in UKMYONET Seronegative Cases
Initial diagnosis n (%) Diagnosis changed (%)Polymyositis 32 (45.1) 13 (40.6)Dermatomyositis 17 (23.9) 3 (17.6)Inclusion Body Myositis 15 (21.1) 1 (6.7)JDM 1 (1.4) 0 (0)Others 6 (8.4) 2 (33)Totals (%) 71 (100) 19 (26.8)Revised final diagnosis (n=19) n (%)
Inclusion body myositis 6 (31.6)Non-myositic/myopathic diagnosis 4 (21.1)
Unspecified (probably genetic) myopathy 4 (21.1)Becker muscular dystrophy 2 (10.5)
Oculopharyngeal muscular dystrophy 1 (5.3)Polymyositis 1 (5.3)
Tubular aggregate myopathy 1 (5.3)Courtesy of Dr James Lilleker
![Page 13: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/13.jpg)
• >50, male predominance• CK < 5x ULN (15 ULN)• Antibody negative (Ro)• Fatty atrophy at presentations• Assymmetrical weakness• Finger flexor/distal
involvement• CK but no clinical response
Inclusion bodiesRimmed vacuoles
HLA-1 upregulation Protein accumulation
COX negative fibres Endomysial inflammation
Histopathology courtesy of Dr Daniel DuPlessis, SRFT
Think about Inclusion Body Myositis…
![Page 14: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/14.jpg)
• >50, male predominance• CK < 5x ULN (15 ULN)• Antibody negative (Ro)• Fatty atrophy at presentations• Assymmetrical weakness• Finger flexor/distal
involvement• CK but no clinical response
Inclusion bodiesRimmed vacuoles
HLA-1 upregulation Protein accumulation
COX negative fibres Endomysial inflammation
Histopathology courtesy of Dr Daniel DuPlessis, SRFTAlso seen in polymyositis
Think about Inclusion Body Myositis…
![Page 15: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/15.jpg)
Treatment of IIM is challenging:diagnosis, assessing disease, treatment success?
Correct diagnosis
• other myopathies may have similar clinical presentation (also PM vs IBM)• inflammation on biopsy does not exclude other diagnoses• treatment resistance should prompt reappraisal of diagnosis
Assessing disease
• muscle weakness… is it activity (ongoing immune-mediated process), or damage (fatty replacement/ atrophy)?• poor prognostic features may direct drug selection/ treatment strategy (lung, cardiac, dysphagia, malignancy)
Treatment success measured as improvement in major manifestations of disease…by muscle strength & improvement in skin rash or organ involvement
![Page 16: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/16.jpg)
MR thighs – axial T1 / STIR
T1 – marked fatty replacementLikely to taken place over many years
STIR – ongoing inflammatory processMR sensitive at picking up inflammationbut not specific for autoimmune disease
![Page 17: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/17.jpg)
MR thighs – axial T1 / STIR
T1 – marked fatty replacementLikely to taken place over many years
STIR – ongoing inflammatory processMR sensitive at picking up inflammationbut not specific for autoimmune disease
![Page 18: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/18.jpg)
Treatment of IIM is challenging:diagnosis, assessing disease, treatment success?
Correct diagnosis
• other myopathies may have similar clinical presentation (also PM vs IBM)• inflammation on biopsy does not exclude other diagnoses• treatment resistance should prompt reappraisal of diagnosis
Assessing disease
• muscle weakness… is it activity (ongoing immune-mediated process), or damage (fatty replacement/ atrophy)?• poor prognostic features may direct drug selection/ treatment strategy (lung, cardiac, dysphagia, malignancy)
Treatment success measured as improvement in major manifestations of disease…by muscle strength & improvement in skin rash or organ involvement
![Page 19: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/19.jpg)
![Page 20: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/20.jpg)
![Page 21: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/21.jpg)
« How do we assess disease activity?« Not just by using CK« Requirement to test more than one muscle group to assess
strength, and also to quantify the result« Parameters are a requirement of the NHS England RTX
MYOACT registry
![Page 22: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/22.jpg)
6 Core Set Measures: Validated and reliable
Domain Core Set Measure Range
Physician Global
ActivityPhysician global VAS (10 cm scale) 0-10
Patient Global ActivityPatient/Parent global VAS (10 cm scale) 0-10
Muscle Strength Composite score of 8 muscle groups
( MMT-8 )0-80
Physical Function Health Assessment Questionnaire (HAQ) score0-3
Laboratory Enzymes Most abnormal enzyme among CK, LDH, AST, ALT, Aldolase Depends on muscle
enzymes
Extramuscular Disease
Activity
Global extramuscular disease activity VAS (10 cm):
constitutional, cutaneous, articular, GI, pulm, cardiac0-10
Slide courtesy of Rohit Aggarwal
Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D,
Pilkington C, Lachenbruch PA, Miller FW; International
Myositis Assesment and Clinical Studies Group. Defining
Clinical Improvement in Adult and Juvenile Myositis. J
Rheumatol. 2003 Mar;30(3):603-17. PMID: 12610824.
![Page 23: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/23.jpg)
https://www.niehs.nih.gov/research/resources/imacs/diseaseactivity/
![Page 24: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/24.jpg)
Manual Muscle Testing - 8
Total Score = 80 (One side + Axial) Slide courtesy of Rohit Aggarwal
![Page 25: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/25.jpg)
1. Manual Muscle Testing - MMT8/MMT26
![Page 26: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/26.jpg)
Kendall Scale
« MRC Scale– 1976– Grade 0-5 - blunt– Informally adapted
with “+” and “-” designations
« Kendall Scale– Florence Kendall– “MRC-plus”– Grade 0-10
![Page 27: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/27.jpg)
2. Patient global disease activity VAS
![Page 28: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/28.jpg)
3. Physician global disease activity VAS
![Page 29: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/29.jpg)
4. Extramuscular disease activity
![Page 30: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/30.jpg)
![Page 31: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/31.jpg)
![Page 32: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/32.jpg)
![Page 33: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/33.jpg)
![Page 34: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/34.jpg)
![Page 35: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/35.jpg)
![Page 36: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/36.jpg)
![Page 37: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/37.jpg)
![Page 38: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/38.jpg)
![Page 39: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/39.jpg)
Extra-muscular global disease activity
Visual Analogue Scale (VAS) 0 – 10 cm
uConstitutional uCutaneousuPulmonaryuGIuJointsuCardiac
= Extra-Muscular Disease Activity
Slide courtesy of Rohit Aggarwal
![Page 40: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/40.jpg)
Health Assessment Questionnaire
W ithout any d ifficu lty
W ith som e d ifficu lty W ith m uch d ifficu lty U nable to do
D ressing/G room ing
Arising
Eating
W alking
H ygiene
Reach
G rip
Activities
Slide courtesy of Rohit Aggarwal
![Page 41: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/41.jpg)
Muscle Enzymes
« Creatine Kinase (CK)« Aldolase« AST« ALT« LDH
![Page 42: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/42.jpg)
FI-3 – measure of endurance
The Functional Index-3 in Adult Dermatomyositis and Polymyositis: Validity and Reliability of an Outcome Measure
for Muscle Endurance. Floranne Ernste, Christopher Chong, Orla Ni Mhuircheartaigh, Tanaz Kermani, Cynthia Crowson, Helene Alexanderson, Ann Reed.
ACR/ARHP Annual Meeting November 11, 2012
Performed FI-3 tasks with as many repetitions possible in 3 minutes
![Page 43: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/43.jpg)
Cutaneous dermatomyositis disease area and severity index
(CDASIv2)
1: Yassaee M, Fiorentino D, Okawa J, Taylor L, Coley C, Troxel AB, Werth VP. Modification of the cutaneous dermatomyositis disease area and severity index,
an outcome instrument. Br J Dermatol. 2010 Mar;162(3):669-73. PubMed PMID: 19863510
2: Anyanwu CO, Fiorentino DF, Chung L, Dzuong C, Wang Y, Okawa J, Carr K, Propert KJ, Werth VP. Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing
disease severity and assessing responsiveness to clinical change. Br J Dermatol. 2015 Oct;173(4):969-74. PubMed PMID: 25994337;
Useful to use as outcome measurein patients with predominant
skin involvement
![Page 44: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/44.jpg)
Recent patient with MDA5 disease
![Page 45: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/45.jpg)
Correlation with disease activityCreatine
kinase
Cardiac
troponin T
Cardiac
troponin I
Absolute
CK-MB
Physician global
disease activity VAS
rho 0.042 0.260 0.218 0.168p 0.776 0.082 0.138 0.271
Patient global disease
activity VAS
rho 0.071 0.106 0.179 0.139p 0.628 0.483 0.224 0.363
HAQrho 0.209 0.330 0.192 0.306p 0.149 0.025 0.192 0.041
Extramuscular global
VAS
rho -0.255 0.036 0.150 -0.076p 0.080 0.812 0.316 0.620
Manual muscle testrho -0.188 -0.403 -0.195 -0.222p 0.196 0.005 0.183 0.142
Rho=Spearman’s ranked correlation coefficient
Lilleker JB, Diederichsen ACP, Jacobsen S, Guy M, Roberts ME, Sergeant JC, Cooper RG, Diederichsen LP, Chinoy H. Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies. Rheumatology
(Oxford). 2018 Mar 12. doi: 10.1093/rheumatology/key031. [Epub ahead of print] PubMed PMID: 29538753
![Page 46: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/46.jpg)
“We have concluded that there is enough evidence to consider making the treatment available”
• Recommendations largely mirror RIM study inclusion criteria etc.
• ~60 patients per year• 500 incident cases• 80% of these will have a relevant
autoantibody• RA protocol for Rituximab
administration
https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2013/04/16036_FINAL.pdf
![Page 47: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/47.jpg)
Is my patient eligible?
« Have myositis…
« Failed steroids
« Failed ≥2 steroid-sparing drugs
« Have myositis relevant autoantibodies
« MMT <125/150 + 2 CSMs (if MMT>125, then 3 CSMs)– Patient global VAS >2/10– Physician global VAS >2/10– HAQ > 0.25– Raised muscle enzyme >1.3 ULN– Global extramuscular activity VAS >1– Active ILD
« Registered with the MYOACT registry
![Page 48: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/48.jpg)
![Page 49: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/49.jpg)
![Page 50: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/50.jpg)
![Page 52: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/52.jpg)
Summary of opportunities for myositis
research
« (UKMYONET) MYOPROSP cross-sectional study– Any myositis patient
« MYOPROSP prospective study– Ideally patients within 2 years of diagnosis or newly
diagnosed– MYOACT – specifically for patients starting RTX
![Page 53: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/53.jpg)
UKMYONET
« Cross-sectional study – understanding of genetic and antibody associations in myositis
« CRN study« Blood test x1« 1 page clinical proforma« >1,600 patients recruited
![Page 54: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/54.jpg)
MYOPROSP« Multi-centre UK study,
commenced Sep 2016« MRC/industry funded« ~80 prospective cases /year« Also opportunity to collect data
cross-sectionally
« Defined workstreams– MYOACT registry – additional
prospective patients commencing on RTX
– Biomarkers– Imaging
– Patient recorded measures (PROMS)
Baseline dataClinical activityBiomarkersPROMS
FU dataClinical activityBiomarkersPROMS
FU dataClinical activityBiomarkersPROMS
FU dataClinical activityBiomarkersPROMS
FU dataClinical activityBiomarkersPROMS
0 3 6 12 24
![Page 55: 07.18 scoring disease activity - University of Manchester · Physical Function Health Assessment Questionnaire (HAQ) score 0-3 Laboratory Enzymes Most abnormal enzyme among CK, LDH,](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf38712e473b33c031fd07/html5/thumbnails/55.jpg)
Acknowledgements
The patients!The University of ManchesterJanine Lamb
Paul New
Robert G. Cooper
William Ollier
Simon Rothwell
Joanna Parkes
James Lilleker
Alex Oldroyd
Philip Day
Fiona MarriageJoanna Cobb
John Bowes
Hazel Platt
Nicolas Pipis
Federico Roncaroli
Mark Roberts
MYOGENIngrid E. Lundberg
Frederick W. Miller
Peter K. GregersenJiri Vencovsky
KatalinDanko
VidyaLimaye
Albert Selva-O'Callaghan
Lauren M. Pachman
Ann M. Reed
Lisa G. Rider
ØyvindMolberg
Olivier Benveniste
PernilleMathiesen
Timothy Radstake
Andrea Doria
Jan De Bleecker
Boel De Paepe
Britta Maurer
Leonid Padyukov
Terrance P. O'Hanlon
Annette Lee
Euromyositis CommitteeLucy Wedderburn
Gouchun Wang
Louise Diedrichson
Jens SchmidtJiri Vencovsky
Paula Oakley
Olivier Benveniste
Ingrid Lundberg
ZitelabNielsKrogh
Mikkel Abildtoft
UKMYONET / MYOPROSPPatrick GordonDavid Isenberg
Mike Hanna
Pedro Machado
Harsha Gunawardena
David Isenberg
Patrick Kiely
James Miller
BathNeil McHugh
Zoe Betteridge